Global Intramuscular Drug Delivery Market Growth (Status and Outlook) 2024-2030

September 2024 | 115 pages | ID: G1570777A4C4EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Intramuscular Drug Delivery market size was valued at US$ million in 2023. With growing demand in downstream market, the Intramuscular Drug Delivery is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.

The research report highlights the growth potential of the global Intramuscular Drug Delivery market. Intramuscular Drug Delivery are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Intramuscular Drug Delivery. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Intramuscular Drug Delivery market.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Key Features:

The report on Intramuscular Drug Delivery market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Intramuscular Drug Delivery market. It may include historical data, market segmentation by Type (e.g., Drug Molecule, Delivery Devices), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Intramuscular Drug Delivery market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Intramuscular Drug Delivery market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Intramuscular Drug Delivery industry. This include advancements in Intramuscular Drug Delivery technology, Intramuscular Drug Delivery new entrants, Intramuscular Drug Delivery new investment, and other innovations that are shaping the future of Intramuscular Drug Delivery.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Intramuscular Drug Delivery market. It includes factors influencing customer ' purchasing decisions, preferences for Intramuscular Drug Delivery product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Intramuscular Drug Delivery market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Intramuscular Drug Delivery market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Intramuscular Drug Delivery market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Intramuscular Drug Delivery industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Intramuscular Drug Delivery market.

Market Segmentation:

Intramuscular Drug Delivery market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type
  • Drug Molecule
  • Delivery Devices
Segmentation by application
  • Infectious Disease
  • Oncology
  • Autoimmune Diseases
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Antares Pharma
  • Eli Lily
  • Galaxo
  • HMD pharmaceuticals
  • Inovio Pharmaceuticals
  • Merck
  • Novartis
  • Pacira Pharmaceuticals
  • Pfizer
  • Pharmajet
  • Teva Pharmaceutical
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Intramuscular Drug Delivery Market Size 2019-2030
  2.1.2 Intramuscular Drug Delivery Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Intramuscular Drug Delivery Segment by Type
  2.2.1 Drug Molecule
  2.2.2 Delivery Devices
2.3 Intramuscular Drug Delivery Market Size by Type
  2.3.1 Intramuscular Drug Delivery Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Intramuscular Drug Delivery Market Size Market Share by Type (2019-2024)
2.4 Intramuscular Drug Delivery Segment by Application
  2.4.1 Infectious Disease
  2.4.2 Oncology
  2.4.3 Autoimmune Diseases
2.5 Intramuscular Drug Delivery Market Size by Application
  2.5.1 Intramuscular Drug Delivery Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Intramuscular Drug Delivery Market Size Market Share by Application (2019-2024)

3 INTRAMUSCULAR DRUG DELIVERY MARKET SIZE BY PLAYER

3.1 Intramuscular Drug Delivery Market Size Market Share by Players
  3.1.1 Global Intramuscular Drug Delivery Revenue by Players (2019-2024)
  3.1.2 Global Intramuscular Drug Delivery Revenue Market Share by Players (2019-2024)
3.2 Global Intramuscular Drug Delivery Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 INTRAMUSCULAR DRUG DELIVERY BY REGIONS

4.1 Intramuscular Drug Delivery Market Size by Regions (2019-2024)
4.2 Americas Intramuscular Drug Delivery Market Size Growth (2019-2024)
4.3 APAC Intramuscular Drug Delivery Market Size Growth (2019-2024)
4.4 Europe Intramuscular Drug Delivery Market Size Growth (2019-2024)
4.5 Middle East & Africa Intramuscular Drug Delivery Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Intramuscular Drug Delivery Market Size by Country (2019-2024)
5.2 Americas Intramuscular Drug Delivery Market Size by Type (2019-2024)
5.3 Americas Intramuscular Drug Delivery Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Intramuscular Drug Delivery Market Size by Region (2019-2024)
6.2 APAC Intramuscular Drug Delivery Market Size by Type (2019-2024)
6.3 APAC Intramuscular Drug Delivery Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Intramuscular Drug Delivery by Country (2019-2024)
7.2 Europe Intramuscular Drug Delivery Market Size by Type (2019-2024)
7.3 Europe Intramuscular Drug Delivery Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Intramuscular Drug Delivery by Region (2019-2024)
8.2 Middle East & Africa Intramuscular Drug Delivery Market Size by Type (2019-2024)
8.3 Middle East & Africa Intramuscular Drug Delivery Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL INTRAMUSCULAR DRUG DELIVERY MARKET FORECAST

10.1 Global Intramuscular Drug Delivery Forecast by Regions (2025-2030)
  10.1.1 Global Intramuscular Drug Delivery Forecast by Regions (2025-2030)
  10.1.2 Americas Intramuscular Drug Delivery Forecast
  10.1.3 APAC Intramuscular Drug Delivery Forecast
  10.1.4 Europe Intramuscular Drug Delivery Forecast
  10.1.5 Middle East & Africa Intramuscular Drug Delivery Forecast
10.2 Americas Intramuscular Drug Delivery Forecast by Country (2025-2030)
  10.2.1 United States Intramuscular Drug Delivery Market Forecast
  10.2.2 Canada Intramuscular Drug Delivery Market Forecast
  10.2.3 Mexico Intramuscular Drug Delivery Market Forecast
  10.2.4 Brazil Intramuscular Drug Delivery Market Forecast
10.3 APAC Intramuscular Drug Delivery Forecast by Region (2025-2030)
  10.3.1 China Intramuscular Drug Delivery Market Forecast
  10.3.2 Japan Intramuscular Drug Delivery Market Forecast
  10.3.3 Korea Intramuscular Drug Delivery Market Forecast
  10.3.4 Southeast Asia Intramuscular Drug Delivery Market Forecast
  10.3.5 India Intramuscular Drug Delivery Market Forecast
  10.3.6 Australia Intramuscular Drug Delivery Market Forecast
10.4 Europe Intramuscular Drug Delivery Forecast by Country (2025-2030)
  10.4.1 Germany Intramuscular Drug Delivery Market Forecast
  10.4.2 France Intramuscular Drug Delivery Market Forecast
  10.4.3 UK Intramuscular Drug Delivery Market Forecast
  10.4.4 Italy Intramuscular Drug Delivery Market Forecast
  10.4.5 Russia Intramuscular Drug Delivery Market Forecast
10.5 Middle East & Africa Intramuscular Drug Delivery Forecast by Region (2025-2030)
  10.5.1 Egypt Intramuscular Drug Delivery Market Forecast
  10.5.2 South Africa Intramuscular Drug Delivery Market Forecast
  10.5.3 Israel Intramuscular Drug Delivery Market Forecast
  10.5.4 Turkey Intramuscular Drug Delivery Market Forecast
  10.5.5 GCC Countries Intramuscular Drug Delivery Market Forecast
10.6 Global Intramuscular Drug Delivery Forecast by Type (2025-2030)
10.7 Global Intramuscular Drug Delivery Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Antares Pharma
  11.1.1 Antares Pharma Company Information
  11.1.2 Antares Pharma Intramuscular Drug Delivery Product Offered
  11.1.3 Antares Pharma Intramuscular Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Antares Pharma Main Business Overview
  11.1.5 Antares Pharma Latest Developments
11.2 Eli Lily
  11.2.1 Eli Lily Company Information
  11.2.2 Eli Lily Intramuscular Drug Delivery Product Offered
  11.2.3 Eli Lily Intramuscular Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Eli Lily Main Business Overview
  11.2.5 Eli Lily Latest Developments
11.3 Galaxo
  11.3.1 Galaxo Company Information
  11.3.2 Galaxo Intramuscular Drug Delivery Product Offered
  11.3.3 Galaxo Intramuscular Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Galaxo Main Business Overview
  11.3.5 Galaxo Latest Developments
11.4 HMD pharmaceuticals
  11.4.1 HMD pharmaceuticals Company Information
  11.4.2 HMD pharmaceuticals Intramuscular Drug Delivery Product Offered
  11.4.3 HMD pharmaceuticals Intramuscular Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 HMD pharmaceuticals Main Business Overview
  11.4.5 HMD pharmaceuticals Latest Developments
11.5 Inovio Pharmaceuticals
  11.5.1 Inovio Pharmaceuticals Company Information
  11.5.2 Inovio Pharmaceuticals Intramuscular Drug Delivery Product Offered
  11.5.3 Inovio Pharmaceuticals Intramuscular Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 Inovio Pharmaceuticals Main Business Overview
  11.5.5 Inovio Pharmaceuticals Latest Developments
11.6 Merck
  11.6.1 Merck Company Information
  11.6.2 Merck Intramuscular Drug Delivery Product Offered
  11.6.3 Merck Intramuscular Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 Merck Main Business Overview
  11.6.5 Merck Latest Developments
11.7 Novartis
  11.7.1 Novartis Company Information
  11.7.2 Novartis Intramuscular Drug Delivery Product Offered
  11.7.3 Novartis Intramuscular Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Novartis Main Business Overview
  11.7.5 Novartis Latest Developments
11.8 Pacira Pharmaceuticals
  11.8.1 Pacira Pharmaceuticals Company Information
  11.8.2 Pacira Pharmaceuticals Intramuscular Drug Delivery Product Offered
  11.8.3 Pacira Pharmaceuticals Intramuscular Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 Pacira Pharmaceuticals Main Business Overview
  11.8.5 Pacira Pharmaceuticals Latest Developments
11.9 Pfizer
  11.9.1 Pfizer Company Information
  11.9.2 Pfizer Intramuscular Drug Delivery Product Offered
  11.9.3 Pfizer Intramuscular Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 Pfizer Main Business Overview
  11.9.5 Pfizer Latest Developments
11.10 Pharmajet
  11.10.1 Pharmajet Company Information
  11.10.2 Pharmajet Intramuscular Drug Delivery Product Offered
  11.10.3 Pharmajet Intramuscular Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
  11.10.4 Pharmajet Main Business Overview
  11.10.5 Pharmajet Latest Developments
11.11 Teva Pharmaceutical
  11.11.1 Teva Pharmaceutical Company Information
  11.11.2 Teva Pharmaceutical Intramuscular Drug Delivery Product Offered
  11.11.3 Teva Pharmaceutical Intramuscular Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
  11.11.4 Teva Pharmaceutical Main Business Overview
  11.11.5 Teva Pharmaceutical Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Intramuscular Drug Delivery Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Drug Molecule
Table 3. Major Players of Delivery Devices
Table 4. Intramuscular Drug Delivery Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Intramuscular Drug Delivery Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Intramuscular Drug Delivery Market Size Market Share by Type (2019-2024)
Table 7. Intramuscular Drug Delivery Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Intramuscular Drug Delivery Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Intramuscular Drug Delivery Market Size Market Share by Application (2019-2024)
Table 10. Global Intramuscular Drug Delivery Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Intramuscular Drug Delivery Revenue Market Share by Player (2019-2024)
Table 12. Intramuscular Drug Delivery Key Players Head office and Products Offered
Table 13. Intramuscular Drug Delivery Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Intramuscular Drug Delivery Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Intramuscular Drug Delivery Market Size Market Share by Regions (2019-2024)
Table 18. Global Intramuscular Drug Delivery Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Intramuscular Drug Delivery Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Intramuscular Drug Delivery Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Intramuscular Drug Delivery Market Size Market Share by Country (2019-2024)
Table 22. Americas Intramuscular Drug Delivery Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Intramuscular Drug Delivery Market Size Market Share by Type (2019-2024)
Table 24. Americas Intramuscular Drug Delivery Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Intramuscular Drug Delivery Market Size Market Share by Application (2019-2024)
Table 26. APAC Intramuscular Drug Delivery Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Intramuscular Drug Delivery Market Size Market Share by Region (2019-2024)
Table 28. APAC Intramuscular Drug Delivery Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Intramuscular Drug Delivery Market Size Market Share by Type (2019-2024)
Table 30. APAC Intramuscular Drug Delivery Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Intramuscular Drug Delivery Market Size Market Share by Application (2019-2024)
Table 32. Europe Intramuscular Drug Delivery Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Intramuscular Drug Delivery Market Size Market Share by Country (2019-2024)
Table 34. Europe Intramuscular Drug Delivery Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Intramuscular Drug Delivery Market Size Market Share by Type (2019-2024)
Table 36. Europe Intramuscular Drug Delivery Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Intramuscular Drug Delivery Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Intramuscular Drug Delivery Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Intramuscular Drug Delivery Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Intramuscular Drug Delivery Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Intramuscular Drug Delivery Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Intramuscular Drug Delivery Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Intramuscular Drug Delivery Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Intramuscular Drug Delivery
Table 45. Key Market Challenges & Risks of Intramuscular Drug Delivery
Table 46. Key Industry Trends of Intramuscular Drug Delivery
Table 47. Global Intramuscular Drug Delivery Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Intramuscular Drug Delivery Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Intramuscular Drug Delivery Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Intramuscular Drug Delivery Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Antares Pharma Details, Company Type, Intramuscular Drug Delivery Area Served and Its Competitors
Table 52. Antares Pharma Intramuscular Drug Delivery Product Offered
Table 53. Antares Pharma Intramuscular Drug Delivery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Antares Pharma Main Business
Table 55. Antares Pharma Latest Developments
Table 56. Eli Lily Details, Company Type, Intramuscular Drug Delivery Area Served and Its Competitors
Table 57. Eli Lily Intramuscular Drug Delivery Product Offered
Table 58. Eli Lily Main Business
Table 59. Eli Lily Intramuscular Drug Delivery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Eli Lily Latest Developments
Table 61. Galaxo Details, Company Type, Intramuscular Drug Delivery Area Served and Its Competitors
Table 62. Galaxo Intramuscular Drug Delivery Product Offered
Table 63. Galaxo Main Business
Table 64. Galaxo Intramuscular Drug Delivery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Galaxo Latest Developments
Table 66. HMD pharmaceuticals Details, Company Type, Intramuscular Drug Delivery Area Served and Its Competitors
Table 67. HMD pharmaceuticals Intramuscular Drug Delivery Product Offered
Table 68. HMD pharmaceuticals Main Business
Table 69. HMD pharmaceuticals Intramuscular Drug Delivery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. HMD pharmaceuticals Latest Developments
Table 71. Inovio Pharmaceuticals Details, Company Type, Intramuscular Drug Delivery Area Served and Its Competitors
Table 72. Inovio Pharmaceuticals Intramuscular Drug Delivery Product Offered
Table 73. Inovio Pharmaceuticals Main Business
Table 74. Inovio Pharmaceuticals Intramuscular Drug Delivery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Inovio Pharmaceuticals Latest Developments
Table 76. Merck Details, Company Type, Intramuscular Drug Delivery Area Served and Its Competitors
Table 77. Merck Intramuscular Drug Delivery Product Offered
Table 78. Merck Main Business
Table 79. Merck Intramuscular Drug Delivery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Merck Latest Developments
Table 81. Novartis Details, Company Type, Intramuscular Drug Delivery Area Served and Its Competitors
Table 82. Novartis Intramuscular Drug Delivery Product Offered
Table 83. Novartis Main Business
Table 84. Novartis Intramuscular Drug Delivery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Novartis Latest Developments
Table 86. Pacira Pharmaceuticals Details, Company Type, Intramuscular Drug Delivery Area Served and Its Competitors
Table 87. Pacira Pharmaceuticals Intramuscular Drug Delivery Product Offered
Table 88. Pacira Pharmaceuticals Main Business
Table 89. Pacira Pharmaceuticals Intramuscular Drug Delivery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Pacira Pharmaceuticals Latest Developments
Table 91. Pfizer Details, Company Type, Intramuscular Drug Delivery Area Served and Its Competitors
Table 92. Pfizer Intramuscular Drug Delivery Product Offered
Table 93. Pfizer Main Business
Table 94. Pfizer Intramuscular Drug Delivery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Pfizer Latest Developments
Table 96. Pharmajet Details, Company Type, Intramuscular Drug Delivery Area Served and Its Competitors
Table 97. Pharmajet Intramuscular Drug Delivery Product Offered
Table 98. Pharmajet Main Business
Table 99. Pharmajet Intramuscular Drug Delivery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Pharmajet Latest Developments
Table 101. Teva Pharmaceutical Details, Company Type, Intramuscular Drug Delivery Area Served and Its Competitors
Table 102. Teva Pharmaceutical Intramuscular Drug Delivery Product Offered
Table 103. Teva Pharmaceutical Intramuscular Drug Delivery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Teva Pharmaceutical Main Business
Table 105. Teva Pharmaceutical Latest Developments

LIST OF FIGURES

Figure 1. Intramuscular Drug Delivery Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Intramuscular Drug Delivery Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Intramuscular Drug Delivery Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Intramuscular Drug Delivery Sales Market Share by Country/Region (2023)
Figure 8. Intramuscular Drug Delivery Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Intramuscular Drug Delivery Market Size Market Share by Type in 2023
Figure 10. Intramuscular Drug Delivery in Infectious Disease
Figure 11. Global Intramuscular Drug Delivery Market: Infectious Disease (2019-2024) & ($ Millions)
Figure 12. Intramuscular Drug Delivery in Oncology
Figure 13. Global Intramuscular Drug Delivery Market: Oncology (2019-2024) & ($ Millions)
Figure 14. Intramuscular Drug Delivery in Autoimmune Diseases
Figure 15. Global Intramuscular Drug Delivery Market: Autoimmune Diseases (2019-2024) & ($ Millions)
Figure 16. Global Intramuscular Drug Delivery Market Size Market Share by Application in 2023
Figure 17. Global Intramuscular Drug Delivery Revenue Market Share by Player in 2023
Figure 18. Global Intramuscular Drug Delivery Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Intramuscular Drug Delivery Market Size 2019-2024 ($ Millions)
Figure 20. APAC Intramuscular Drug Delivery Market Size 2019-2024 ($ Millions)
Figure 21. Europe Intramuscular Drug Delivery Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Intramuscular Drug Delivery Market Size 2019-2024 ($ Millions)
Figure 23. Americas Intramuscular Drug Delivery Value Market Share by Country in 2023
Figure 24. United States Intramuscular Drug Delivery Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Intramuscular Drug Delivery Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Intramuscular Drug Delivery Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Intramuscular Drug Delivery Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Intramuscular Drug Delivery Market Size Market Share by Region in 2023
Figure 29. APAC Intramuscular Drug Delivery Market Size Market Share by Type in 2023
Figure 30. APAC Intramuscular Drug Delivery Market Size Market Share by Application in 2023
Figure 31. China Intramuscular Drug Delivery Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Intramuscular Drug Delivery Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Intramuscular Drug Delivery Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Intramuscular Drug Delivery Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Intramuscular Drug Delivery Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Intramuscular Drug Delivery Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Intramuscular Drug Delivery Market Size Market Share by Country in 2023
Figure 38. Europe Intramuscular Drug Delivery Market Size Market Share by Type (2019-2024)
Figure 39. Europe Intramuscular Drug Delivery Market Size Market Share by Application (2019-2024)
Figure 40. Germany Intramuscular Drug Delivery Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Intramuscular Drug Delivery Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Intramuscular Drug Delivery Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Intramuscular Drug Delivery Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Intramuscular Drug Delivery Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Intramuscular Drug Delivery Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Intramuscular Drug Delivery Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Intramuscular Drug Delivery Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Intramuscular Drug Delivery Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Intramuscular Drug Delivery Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Intramuscular Drug Delivery Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Intramuscular Drug Delivery Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Intramuscular Drug Delivery Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Intramuscular Drug Delivery Market Size 2025-2030 ($ Millions)
Figure 54. APAC Intramuscular Drug Delivery Market Size 2025-2030 ($ Millions)
Figure 55. Europe Intramuscular Drug Delivery Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Intramuscular Drug Delivery Market Size 2025-2030 ($ Millions)
Figure 57. United States Intramuscular Drug Delivery Market Size 2025-2030 ($ Millions)
Figure 58. Canada Intramuscular Drug Delivery Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Intramuscular Drug Delivery Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Intramuscular Drug Delivery Market Size 2025-2030 ($ Millions)
Figure 61. China Intramuscular Drug Delivery Market Size 2025-2030 ($ Millions)
Figure 62. Japan Intramuscular Drug Delivery Market Size 2025-2030 ($ Millions)
Figure 63. Korea Intramuscular Drug Delivery Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Intramuscular Drug Delivery Market Size 2025-2030 ($ Millions)
Figure 65. India Intramuscular Drug Delivery Market Size 2025-2030 ($ Millions)
Figure 66. Australia Intramuscular Drug Delivery Market Size 2025-2030 ($ Millions)
Figure 67. Germany Intramuscular Drug Delivery Market Size 2025-2030 ($ Millions)
Figure 68. France Intramuscular Drug Delivery Market Size 2025-2030 ($ Millions)
Figure 69. UK Intramuscular Drug Delivery Market Size 2025-2030 ($ Millions)
Figure 70. Italy Intramuscular Drug Delivery Market Size 2025-2030 ($ Millions)
Figure 71. Russia Intramuscular Drug Delivery Market Size 2025-2030 ($ Millions)
Figure 72. Spain Intramuscular Drug Delivery Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Intramuscular Drug Delivery Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Intramuscular Drug Delivery Market Size 2025-2030 ($ Millions)
Figure 75. Israel Intramuscular Drug Delivery Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Intramuscular Drug Delivery Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Intramuscular Drug Delivery Market Size 2025-2030 ($ Millions)
Figure 78. Global Intramuscular Drug Delivery Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Intramuscular Drug Delivery Market Size Market Share Forecast by Application (2025-2030)